Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024

Description:

Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy. Download a free sale report here @ – PowerPoint PPT presentation

Number of Views:24

less

Transcript and Presenter's Notes

Title: Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024


1
Oncology Drugs Market Report, By Therapeutic
Modules, Cancer Type and Geography Global
Market Share, Trend Analysis and Forecast up to
2024
Email sales_at_axiommrc.com
2
The global oncology drugs market revenue is
estimated to reach USD 202.13 Billion by 2024
expanding at a CAGR of 7.8 from 2019 to
2024. Immunotherapies/ biologics are emerging as
potential therapies to find the permanent cure
for various cancer types. Amongst various
biologics, drugs based on monoclonal antibodies
(mAbs) have gained significant attention in
recent years due to their high efficacy. Key
driving factors of the Oncology drug market The
cancer drugs market is driven by the growing
prevalence of various types of cancer,
increasing demand of biological and targeted drug
therapies, continuous patent expiry of key
cancer drugs and the rising impact of
biosimilars. However, the high cost of drug
development, the threat of failure and the
adverse effects of cancer drug therapy,
particularly chemotherapy, hinders the market
growth. Developed nations have implemented strict
regulations for the design and development of
cancer drugs. USFDA and European Union have
undertaken significant initiatives to fuel the
growth of the cancer drugs market by providing
pre-market approval for potential drugs under
clinical development. Download a free sale
report here _at_ https//axiommrc.com/request-for-
sample/?report1397 The global oncology drugs
market is segmented on the basis of therapeutic
modules, cancer type and geography. Based on
the therapeutic modules
The market
is segmented into chemotherapy, targeted therapy,
immunotherapy, hormonal therapy and others. On
the basis of cancer type The global oncology
drugs market is segmented into blood cancer,
breast cancer, gastrointestinal cancer, prostate
cancer, lung cancer, skin cancer and others.
3
By geography The market is fragmented into North
America, Europe, Asia Pacific, Middle East and
Africa and Latin America. North America is
anticipated to remain the leading region over
the forecast period from 2018 to 2024. Demand for
cancer drugs was highest in North America
especially in the U.S. Get more detail about
this report _at_ https//axiommrc.com/speak-to-
analyst/?report1397 North America dominates
the market for cancer drugs as the region houses
companies engaged in the development of cancer
drugs. Additionally, the disposable incomes of
consumers and health insurance cover for life-
threatening diseases in North America are very
high which increases the affordability of cancer
treatment. In recent years, US Food and Drug
Administration (USFDA) has taken initiatives to
support the growth of cancer drugs market by
providing pre-market approval to the drugs, which
are in the clinical phase thus, accelerating
the clinical development. Asia Pacific is
expected to be the moderate growing region in
cancer drugs market during the forecast period.
Moreover, the Middle East and Africa and Latin
America are also expected to show moderate
growth for this market in the years to
come. Buy this report _at_ https//axiommrc.com/buy
-now/? Some of the key players operating in the
oncology drugs market with most significant
product development include and are not limited
to Amgen Inc., Johnson and Johnson, Roche
Diagnostics, GlaxoSmithKline PLC, Merck
Company, Novartis AG, Pfizer, Sanofi, Eli Lilly
and Company, Celgene Corporation, Bayer, Amgen,
Merck, Bristol-Myers Squibb, Ariad
Pharmaceuticals, Hoffmann-La Roche Ltd,
Boehringer Ingelheim GmbH, and Teva
Pharmaceuticals among others.
4
About Us Axiom Market Research Consulting
(also known as Axiom MRC), is a full- service
market research and data analytics firm, driven
by a simple aim of providing key market
intelligence to companies to assist them in
taking informed business decisions pertaining to
their marketing strategy, investments, new
product launches, market competition, consumer or
end users, social media trends etc. Contact
Us United States 616 Corporate Way, Suite 2-4268
Valley Cottage, NY 10989 Telephone 1 (845)
875-9786 Email sales_at_axiommrc.com
Write a Comment
User Comments (0)
About PowerShow.com